Olesya Gennadievna Makarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olesya Gennadievna Makarova has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Olesya Nikolayevna Mazko
Altai State Medical University, Barnaul
6 shared publications - Aleksandr Yurievich Zharikov
Алтайский государственный медицинский университет
4 shared publications - Igor Petrovich Bobrov
Altai State Medical University
4 shared publications O.N. Mazko
3 shared publicationsA.Yu. Zharikov
2 shared publications- Artem Sergeevich Kalnitsky
Altai State Medical University
2 shared publications
Latest Publications
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 79-83
AN INVESTIGATION INTO THE TOXIC EFFECTS OF A DIETARY SUPPLEMENT MADE FROM LION'S MANE MUSHROOM FOLLOWING A ONE-TIME DOSE
Introduction. The quest for neuroprotective agents has become increasingly critical due to the rising prevalence of neurodegenerative diseases linked to an aging demographic. A multi-faceted formulation has been created, incorporating Hericium erinaceus biomass, extracts from Eleutherococcus senticosus and Camellia sinensis, B vitamins, and succinic acid, which operates through multitarget mechanisms. Objective. This study aimed to assess the toxicometric characteristics of the formulation following a single oral dose administration. Materials and Methods. The study focused on the composition (H. erinaceus mycelium and fruiting body – 250 mg; extracts of Eleutherococcus and green tea – 100 mg each; succinic acid – 100 mg; vitamins B6 and B2 – 5 mg each; inositol – 1 mg; folic acid – 0.4 mg). The experiment was carried out on outbred Wistar rats of both genders (weight range 210–256 g) in accordance with OECD Guideline No. 423. Three experimental groups were established (doses of 500, 2000, and 5000 mg/kg) along with an intact control group (n = 10 per group). Observations were made over a 14-day period, monitoring mortality, clinical signs, behavioral changes, body weight fluctuations, and blood biochemistry parameters (ALT, AST, glucose, bilirubin, creatinine, urea, and lipids). Results. No fatalities were observed in any of the groups. Behavioral modifications were restricted to a temporary rise in locomotor activity. There were no indications of acute intoxication. Based on K.K. Sidorov's classification, an LD50 greater than 5000 mg/kg is categorized as hazard class IV, which includes "Low-toxic substances". No statistically significant alterations in liver cytolysis markers (ALT, AST) or indicators of the hepatobiliary system (bilirubin) were found. A hypoglycemic effect was noted, with glucose levels decreasing to 3.45–3.30 mmol/L at doses of 2000 and 5000 mg/kg (p < 0.001), alongside a moderate reduction in creatinine and fluctuations in urea levels, all without evidence of nephrotoxicity. Conclusion. A single intragastric administration of the formulation at doses up to 5000 mg/kg classifies it as a low-toxicity compound (LD50>5000 mg/kg). The formulation was considered safe for subsequent extended preclinical trials aimed at evaluating specific neuroprotective and immunomodulatory effects, and it also holds potential as a metabolic corrector for carbohydrate metabolism.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (3) , 79-83
AN INVESTIGATION INTO THE TOXIC EFFECTS OF A DIETARY SUPPLEMENT MADE FROM LION'S MANE MUSHROOM FOLLOWING A ONE-TIME DOSE
Introduction. The quest for neuroprotective agents has become increasingly critical due to the rising prevalence of neurodegenerative diseases linked to an aging demographic. A multi-faceted formulation has been created, incorporating Hericium erinaceus biomass, extracts from Eleutherococcus senticosus and Camellia sinensis, B vitamins, and succinic acid, which operates through multitarget mechanisms. Objective. This study aimed to assess the toxicometric characteristics of the formulation following a single oral dose administration. Materials and Methods. The study focused on the composition (H. erinaceus mycelium and fruiting body – 250 mg; extracts of Eleutherococcus and green tea – 100 mg each; succinic acid – 100 mg; vitamins B6 and B2 – 5 mg each; inositol – 1 mg; folic acid – 0.4 mg). The experiment was carried out on outbred Wistar rats of both genders (weight range 210–256 g) in accordance with OECD Guideline No. 423. Three experimental groups were established (doses of 500, 2000, and 5000 mg/kg) along with an intact control group (n = 10 per group). Observations were made over a 14-day period, monitoring mortality, clinical signs, behavioral changes, body weight fluctuations, and blood biochemistry parameters (ALT, AST, glucose, bilirubin, creatinine, urea, and lipids). Results. No fatalities were observed in any of the groups. Behavioral modifications were restricted to a temporary rise in locomotor activity. There were no indications of acute intoxication. Based on K.K. Sidorov's classification, an LD50 greater than 5000 mg/kg is categorized as hazard class IV, which includes "Low-toxic substances". No statistically significant alterations in liver cytolysis markers (ALT, AST) or indicators of the hepatobiliary system (bilirubin) were found. A hypoglycemic effect was noted, with glucose levels decreasing to 3.45–3.30 mmol/L at doses of 2000 and 5000 mg/kg (p < 0.001), alongside a moderate reduction in creatinine and fluctuations in urea levels, all without evidence of nephrotoxicity. Conclusion. A single intragastric administration of the formulation at doses up to 5000 mg/kg classifies it as a low-toxicity compound (LD50>5000 mg/kg). The formulation was considered safe for subsequent extended preclinical trials aimed at evaluating specific neuroprotective and immunomodulatory effects, and it also holds potential as a metabolic corrector for carbohydrate metabolism.
- Open Access
- 16 July 2023
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 17 (3) , 321-331
Assessing radonotherapy effectiveness and modulated steroidogenesis in experimental chronic endometritis model
Aim: to evaluate therapeutic efficacy and modulated steroidogenesis after radon therapy in experimental chronic endometritis model.Materials and Мethods. A therapeutic effect related to radon mineral waters was studied experimentally. The water radon concentration was 5.4–6.2 nCi/dm3. The experimental endometritis was induced in laboratory Wistar line rats (n = 40) inoculated with intra-uterine self-fecal suspension. Experimental group animals (n = 10) received a wide-spectrum antibiotic Ceftriaxone within 7 days followed by applying 10 procedures of radon therapy one a day and from day 41, the first procedure lasting 5 minutes, the second – 8 minutes, the third – 10 minutes, with all other procedures – for 15 minutes. Comparison group I animals (n = 10) received antibacterial therapy, radon therapy and 10 procedures of peloid therapy with natural salt-saturated medium sulfide silt therapeutic mud according to a radon therapy regimen. Сomparison group II (n = 10) received antibacterial and peloid therapy according to comparison group I regimen. Control group (n = 10) received no treatment. Inflammatory signs were assessed by endometrium histology study. The venous steroid hormones levels were analyzed by enzyme-linked immunosorbent assay.Results. In experimental vs. control group, it was found that endometrial diffuse infiltrate was of lower density comprising 125.4 ± 8.1 vs. 180.7 ± 9.0 immunocompetent cells (by 30.7%; p = 0.002), whereas in comparison group I, density of inflammatory infiltration was minimal (reduced by 88.7 % compared to control group; p < 0.001) and reached 20.5 ± 1.8 cells. In the experimental group as well as comparison groups I and II vs. control group, a significant increased level of serum progesterone was observed after treatment (p = 0.008). When using a radon therapy in experimental group, it resulted in a more prominent rise in progesterone level compared to peloid therapy in comparison group II. Radon balneotherapy was found in main control group to elicit a significant declined estradiol level (p = 0.008), but not in comparison groups I and II featured with no significant change in estradiol level compared to control group.Conclusion. Radon therapy exerts an anti-inflammatory effect in experimental chronic endometritis model. Radon therapy combined with peloid therapy has a potentiated effect. The use of radon balneotherapy is accompanied by significantly increased progesterone and decreased estradiol level suggesting to conduct clinical trials for confirming its effectiveness in patients with reproductive dysfunction including diseases accompanied by hyperestrogenism.
- 16 July 2023
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 17 (3) , 321-331
Open AccessAssessing radonotherapy effectiveness and modulated steroidogenesis in experimental chronic endometritis model
Aim: to evaluate therapeutic efficacy and modulated steroidogenesis after radon therapy in experimental chronic endometritis model.Materials and Мethods. A therapeutic effect related to radon mineral waters was studied experimentally. The water radon concentration was 5.4–6.2 nCi/dm3. The experimental endometritis was induced in laboratory Wistar line rats (n = 40) inoculated with intra-uterine self-fecal suspension. Experimental group animals (n = 10) received a wide-spectrum antibiotic Ceftriaxone within 7 days followed by applying 10 procedures of radon therapy one a day and from day 41, the first procedure lasting 5 minutes, the second – 8 minutes, the third – 10 minutes, with all other procedures – for 15 minutes. Comparison group I animals (n = 10) received antibacterial therapy, radon therapy and 10 procedures of peloid therapy with natural salt-saturated medium sulfide silt therapeutic mud according to a radon therapy regimen. Сomparison group II (n = 10) received antibacterial and peloid therapy according to comparison group I regimen. Control group (n = 10) received no treatment. Inflammatory signs were assessed by endometrium histology study. The venous steroid hormones levels were analyzed by enzyme-linked immunosorbent assay.Results. In experimental vs. control group, it was found that endometrial diffuse infiltrate was of lower density comprising 125.4 ± 8.1 vs. 180.7 ± 9.0 immunocompetent cells (by 30.7%; p = 0.002), whereas in comparison group I, density of inflammatory infiltration was minimal (reduced by 88.7 % compared to control group; p < 0.001) and reached 20.5 ± 1.8 cells. In the experimental group as well as comparison groups I and II vs. control group, a significant increased level of serum progesterone was observed after treatment (p = 0.008). When using a radon therapy in experimental group, it resulted in a more prominent rise in progesterone level compared to peloid therapy in comparison group II. Radon balneotherapy was found in main control group to elicit a significant declined estradiol level (p = 0.008), but not in comparison groups I and II featured with no significant change in estradiol level compared to control group.Conclusion. Radon therapy exerts an anti-inflammatory effect in experimental chronic endometritis model. Radon therapy combined with peloid therapy has a potentiated effect. The use of radon balneotherapy is accompanied by significantly increased progesterone and decreased estradiol level suggesting to conduct clinical trials for confirming its effectiveness in patients with reproductive dysfunction including diseases accompanied by hyperestrogenism.
- 1 January 2022
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 4,p. 109-115
HORMONAL CHANGES IN THE BLOOD OF RATS WHEN USING THE EXTRACT FROM MARAL ANTLERS "AQUAPANTY"
- 1 January 2022
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 4,p. 109-115
HORMONAL CHANGES IN THE BLOOD OF RATS WHEN USING THE EXTRACT FROM MARAL ANTLERS "AQUAPANTY"
- 1 January 2022
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 1,p. 43-51
NEW EXPERIMENTAL MODEL OF MIXED URATE-OXALATE NEPHROLITHIASIS
- 1 January 2022
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 1,p. 43-51
NEW EXPERIMENTAL MODEL OF MIXED URATE-OXALATE NEPHROLITHIASIS
- Open Access
- 18 July 2021
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 20 (2) , 29-35-35
The role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
Роль свободнорадикального окисления в почках в нефропротекторном действии блокатора минералокортикоидных рецепторов эплеренона при экспериментальном сахарном диабете
- 18 July 2021
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 20 (2) , 29-35-35
Open AccessThe role of free radical oxidation in the kidneys in the nephroprotective action of eplerenone, a mineralocorticoid receptor antagonist, in experimental diabetes mellitus
Роль свободнорадикального окисления в почках в нефропротекторном действии блокатора минералокортикоидных рецепторов эплеренона при экспериментальном сахарном диабете
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (5) , 46-50
Molecular features of nephropathy associated with disorder of urate metabolism
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (5) , 46-50
Molecular features of nephropathy associated with disorder of urate metabolism
- 1 January 2021
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 2,p. 105-110
EFFECT OF CARNOSINE ON THE COURSE OF EXPERIMENTAL OXALATE NEPHROLITHIASIS
- 1 January 2021
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 2,p. 105-110
EFFECT OF CARNOSINE ON THE COURSE OF EXPERIMENTAL OXALATE NEPHROLITHIASIS
- Open Access
- 1 January 2017
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 2(6),p. 11-13
ANTI-INFLAMMATORY ACTIVITY OF GALIUM VERUM HERB INFUSION
- 1 January 2017
- Published by Altay State Medical University in Bulletin of Medical Science
- No. 2(6),p. 11-13
Open AccessANTI-INFLAMMATORY ACTIVITY OF GALIUM VERUM HERB INFUSION